Meltzer Jonathan C 4

What Happened

• Jonathan C. Meltzer, EVP, Operations at Labcorp Holdings (LH), reported a small open-market sale and new equity awards on 2026-02-10. He sold 91 shares at $276.79 each for total proceeds of $25,188 under a pre-arranged plan. At the same time he was granted 1,900 stock options and 620 restricted stock units (RSUs) as awards (derivative transactions reported at $0.00).

Key Details

• Transaction date: February 10, 2026; Form 4 filed February 12, 2026 (timely).
• Sale: 91 shares sold at $276.79 each — total $25,188. (Transaction code S; sale executed pursuant to a Rule 10b5-1 plan.)
• Awards: 1,900 employee stock options (granted under the 2025 Omnibus Incentive Plan) and 620 RSUs (each RSU represents the right to one share).
• Vesting: Options and RSUs vest in three equal annual installments (RSUs begin vesting Feb 10, 2027 per the filing).
• Shares owned after transaction: Not specified in the provided filing summary.
• Footnotes: F1 = sale pursuant to a Rule 10b5-1 plan; F2–F3 = option grant and standard multi-year vesting; F4–F6 = RSU details and aggregate count.

Context

• The sale was small (~$25k) and executed under a 10b5-1 plan, which typically indicates a pre-planned, routine disposition rather than an ad hoc sell decision. The awards are standard executive compensation (options and RSUs) that vest over time and do not represent an immediate purchase of stock by the insider. As always, these filings are factual disclosures and do not, by themselves, indicate the insider’s market view.